ArticleProstate cancer and prostatic diseases2024

Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials.

Wataru Fukuokaya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.